Video
We're human with Connie O'Donnell
Head of Sales & Marketing Connie O’Donnell discusses the move from animal models to human iPSC-derived models in drug discovery. She explains how advances in genomics, CRISPR and data analytics are making precise human disease modelling possible, and why more predictive preclinical data could mean fewer late-stage failures and a second look at previously shelved drug candidates.
Watch more interviews from this series
Head of Sales & Marketing Connie O’Donnell discusses the move from animal models to human iPSC-derived models in drug discovery. She explains how advances in genomics, CRISPR and data analytics are making precise human disease modelling possible, and why more predictive preclinical data could mean fewer late-stage failures and a second look at previously shelved drug candidates.